Gate.io Completes Rifampicin (RIFAMPICIN) Rebranding to Rifampicin (RIFSOL) and to Resume Trading

We are pleased to announce that Rifampicin (RIFAMPICIN) has been successfully rebranded to Rifampicin (RIFSOL) on Gate.io, and the token has been relisted on Gate.io with the new trading symbol RIFSOL. Users can now view your updated balances in the Transaction History.It is important to note that the rebranding is merely a change in name and does not involve any blockchain migration.Gate.io will commence RIFSOL trading from November 20, 2024, 09:00 UTC, and will support both its deposit and withdrawal services. As the market for RIFSOL may experience significant fluctuations after trading resumes, we strongly advise users to be aware of the associated risks and exercise caution.

Important Notes:1.After the rebranding, balances migrated from Pilot to the Spot account will temporarily be unavailable for trading until it is fully delisted from Pilot. Please carefully consider this before proceeding to avoid potential financial loss.2.Users must complete the balance migration to the Spot account within 24 hours of its delisting from Pilot. Accounts failing to complete the migration by the deadline will no longer be processed automatically. Therefore, please complete the migration promptly to ensure the safety of your assets and uninterrupted trading.3.If you cannot complete the migration within the specified timeframe, please contact our customer service team promptly for necessary support and assistance.

For more details, refer to:Gate.io Supports Rifampicin (RIFAMPICIN) Rebranding to Rifampicin (RIFSOL)

Deposit RIFSOL: https://www.gate.io/myaccount/deposit/RIFSOLTrade RIFSOL: https://www.gate.io/trade/RIFSOL_USDT